SEC Form 4 · accession 0001179110-16-027275
Egalet Corp · EGLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey M. Dayno
Officer — Chief Medical Officer
Period of report
Jun 30, 2016
Accepted (ET)
Jul 5, 2016 · 10:53 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001586105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 30, 2016 | S | 536 | $4.65 | D | 19,820 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale effected pursuant to a Rule 10b5-1 trading plan to pay tax liability on vesting restricted stock. The restricted stock was originally granted on August 6, 2014.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.